Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 5Unknown 2Active not recruiting 2Terminated 1

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Colorectal Neoplasms 2Adenoma 2Neoplasms 1Cystic Fibrosis 1

Interventions

Bevacizumab 30pembrolizumab 29Oxaliplatin 28Leucovorin 25Fluorouracil 24Irinotecan 22Cetuximab 22Capecitabine 19Nivolumab 15Specimen Handling 12atezolizumab 11Panitumumab 11Colonoscopy 9Carboplatin 9regorafenib 8Biopsy 8trifluridine tipiracil drug combination 7Trifluridine 7Paclitaxel 7Aspirin 7balstilimab 6Standard of Care 6Cisplatin 6tislelizumab 5encorafenib 5Radiotherapy 5Magnetic Resonance Spectroscopy 5Immunoglobulin G 5Folfox protocol 5Disulfides 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Active not recruiting × Colorectal Neoplasms × Occult Blood × Clear all
NCT01538550 2026-04-14

Pilot Study of a National Screening Programme for Bowel Cancer in Norway

Norwegian Institute of Public Health

Phase NA Active not recruiting
140,000 enrolled
Gastrointestinal

Adenoma, Neoplasms, Colorectal Neoplasms

NCT05362344 2026-03-24

NICE-CF

University of Washington, the Collaborative Health Studies Coordinating Center

Active not recruiting
350 enrolled
Gastrointestinal

Adenoma, Cystic Fibrosis, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡